Aortic Arch Syndromes: Clinical Trials

8 trials for Aortic Arch Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 1 active not recruiting, 1 not yet recruiting. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Unknown 3, Completed 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 21Unknown 1

Follow Aortic Arch Syndromes: new trials by email Literature Review of Aortic Arch Syndromes trials Research Report on Aortic Arch Syndromes

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention
Azithromycin 40 MG/ML, Placebo - Tracheomalacia, Bronchopulmonary Dysplasia (BPD)
Phase 3Not yet recruitingCopenhagen University Hospital, Rigshospitalet1502024-09-012024-05-14
Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
Tofacitinib 5 MG, Prednisolone, Placebo of tofacitinib 5mg - Takayasu Arteritis
Phase 3UnknownChinese SLE Treatment And Research Group502023-01-202023-03-01
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
Ustekinumab, Placebo, Glucorticoid Taper Regimen - Takayasu Arteritis
Phase 3TerminatedJanssen Pharmaceutical K.K.142021-09-152025-04-29
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
Upadacitinib, Placebo for Upadacitinib, Prednisolone - Takayasu Arteritis (TAK)
Phase 3Active not recruitingAbbVie562020-02-042026-02-18
Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis
Angioplasty with paclitaxel eluting balloon, Angioplasty with plain old balloon - Hypertension, Renovascular
Phase 3UnknownPeking Union Medical College Hospital902019-10-012020-04-29
Anti-inflammatory Treatment for Inactive Takayasu Arteritis
Prednisone, cyclophosphamide - Takayasu Arteritis, Anti-Inflammatory Agents
Phase 2 / Phase 3UnknownChinese Academy of Medical Sciences, Fuwai Hospital402018-06-012018-06-08
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis
MMF, CYC, Glucocorticoids - Takayasu Arteritis
Phase 3CompletedChinese SLE Treatment And Research Group1382017-03-162023-08-30
Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
Tocilizumab - TAKAYASU ARTERITIS
Phase 3CompletedAssistance Publique - Hôpitaux de Paris182014-06-102020-08-19

Narrower conditions

Takayasu Arteritis (7)  ·  Bronchiectasis (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Cystic Disease Of Lung (1)  ·  Fibromuscular Dysplasia (1)  ·  Hypertension, Renovascular (1)  ·  Renal Artery Obstruction (1)  ·  Tracheomalacia (1)  ·  Vascular Ring (1)

Broader conditions

Aortic Diseases (8)  ·  Cardiovascular Diseases (8)  ·  Skin and Connective Tissue Diseases (8)  ·  Vascular Diseases (8)  ·  Arteritis (7)  ·  Skin Diseases (7)  ·  Skin Diseases, Vascular (7)  ·  Vasculitis (7)  ·  Arterial Occlusive Diseases (1)  ·  Bronchial Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Cartilage Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Prednisolone (2)  ·  Angioplasty (1)  ·  Azithromycin (1)  ·  Cyclophosphamide (1)  ·  Glucocorticoids (1)  ·  Prednisone (1)  ·  Ustekinumab (1)  ·  tocilizumab (1)  ·  tofacitinib (1)  ·  upadacitinib (1)

Sponsors

Chinese SLE Treatment And Research Group (2)  ·  AbbVie (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Janssen Pharmaceutical K.K. (1)  ·  Peking Union Medical College Hospital (1)

Countries

China (4)  ·  Japan (2)  ·  Argentina (1)  ·  Brazil (1)  ·  France (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Xinping Tian, MD (2)  ·  Xiongjing Jiang, MD (1)  ·  Yuehong Zheng, MD (1)

Results publications

PMID 10068416, PMID 16221103, PMID 17332971, PMID 20054700, PMID 27924855, PMID 32943098, PMID 40104212